What are the major opportunities in the Benign Prostatic Hyperplasia Treatment market? What are the strategies for the Benign Prostatic Hyperplasia Treatment market?

For detailed insights on the major opportunities and strategies in the Benign Prostatic Hyperplasia Treatment market, Read More

How does the Benign Prostatic Hyperplasia Treatment market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Benign Prostatic Hyperplasia Treatment market growth and SWOT analysis of the Benign Prostatic Hyperplasia Treatment industry, Read More

Global Benign Prostatic Hyperplasia Treatment Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Benign Prostatic Hyperplasia Treatment Global Market Report 2025

Name: Benign Prostatic Hyperplasia Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment (Minimal Invasive Surgery, Invasive Surgery), By Therapeutic Class (Alpha Blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Other Therapeutic classes), By End User (Home Healthcare, Hospitals And Clinics, Research And Manufacturing) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Benign Prostatic Hyperplasia Treatment Market Overview

• Benign Prostatic Hyperplasia Treatment market size has reached to $8.23 billion in 2024

• Expected to grow to $10.74 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%

• Growth Driver: Rising Adoption Of Minimally Invasive Surgeries Driving Growth In BPH Treatment

• Market Trend: Innovative Approaches In Benign Prostatic Hyperplasia Treatment Minimally Invasive Techniques For Enhanced Recovery

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Benign Prostatic Hyperplasia Treatment Market?

Benign prostatic hyperplasia (BPH) treatment refers to medical, minimally invasive, and surgical approaches used to manage the symptoms of an enlarged prostate. BPH is a common condition in aging men, leading to urinary issues such as frequent urination, weak stream, and incomplete bladder emptying.

The main treatments of benign prostatic hyperplasia (BPH) include minimally invasive surgery (MIS) and invasive surgery. Minimally Invasive Surgery (MIS) refers to surgical techniques that use small incisions, specialized instruments, and advanced imaging technology to perform procedures with minimal trauma to the body. The therapeutic classes for BPH treatment include alpha blockers, 5-alpha reductase inhibitors, phosphodiesterase-5 inhibitors, and other therapeutic classes. These treatments cater to various end users, including Home Healthcare, hospitals and clinics, as well as research and manufacturing facilities.

Benign Prostatic Hyperplasia Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Benign Prostatic Hyperplasia Treatment Market Size 2025 And Growth Rate?

What Is The Benign Prostatic Hyperplasia Treatment Market Growth Forecast?

The benign prostatic hyperplasia treatment market size is expected to see strong growth in the next few years. It will grow to $10.74 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to the rising adoption of minimally invasive procedures, a growing number of geriatric patients, a rising availability of advanced treatment options, a growing focus on patient-centric care, and a rising prevalence of comorbidities. Major trends in the forecast period include developing targeted therapies, integration of digital health solutions, innovation in surgical options, integration of 3D imaging for diagnosis, and innovation in patient-centered care models.

The forecast of 5.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. urology by inflating prices of laser prostatectomy systems and alpha-blocker medications developed in Germany and India, resulting in prolonged urinary symptoms and higher surgical intervention costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Benign Prostatic Hyperplasia Treatment Market Segmented?

1) By Treatment: Minimal Invasive Surgery, Invasive Surgery

2) By Therapeutic Class: Alpha Blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Other Therapeutic classes

3) By End User: Home Healthcare, Hospitals And Clinics, Research And Manufacturing

Subsegments:

1) By Minimal Invasive Surgery: Transurethral Resection of the Prostate (TURP), Laser Surgery, Prostatic Urethral Lift, Transurethral Incision of the Prostate (TUIP), Microwave Therapy

2) By Invasive Surgery: Open Prostatectomy, Robotic Prostatectomy

What Is Driving The Benign Prostatic Hyperplasia Treatment Market? Rising Adoption Of Minimally Invasive Surgeries Driving Growth In BPH Treatment

The rise in adoption of minimally invasive surgeries is expected to propel the growth of the benign prostatic hyperplasia treatment market going forward. Minimally invasive surgeries are procedures that involve small incisions or no incisions at all, using specialized instruments to reduce recovery time, pain, and risk of complications. The rise in adoption of minimally invasive surgeries is driven by benefits such as shorter recovery times, reduced pain, lower risk of complications, and improved cosmetic outcomes. Benign prostatic hyperplasia treatment through minimally invasive surgeries provides patients with reduced recovery times, lower risks of complications, and effective symptom relief, enhancing overall surgical outcomes. For instance, in September 2023, according to the American Society of Plastic Surgeons (ASPS), a US-based professional association, in 2022, a total of 23,672,269 cosmetic minimally invasive procedures were performed globally, including treatments such as neuromodulator injections, lip augmentation, and non-invasive skin tightening. Therefore, the rise in adoption of minimally invasive surgeries is driving the growth of the benign prostatic hyperplasia treatment industry.

Who Are The Major Players In The Global Benign Prostatic Hyperplasia Treatment Market?

Major companies operating in the benign prostatic hyperplasia treatment market are Pfizer Inc., Merck And Co Inc, AbbVie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Public Limited Company, Medtronic Public Limited Company, Mezzion Pharma Co Ltd, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Boston Scientific Corporation, Astellas Pharma Inc., Olympus Corporation, Coloplast Group, Teleflex Incorporated, Cook Medical Incorporated, AngioDynamics, Inc., HistoSonics Inc, Urovant Sciences Ltd, UroGen Pharma Ltd., Urologix Inc, Zenflow Inc, Butterfly Medical Ltd.

What Are The Key Trends Of The Global Benign Prostatic Hyperplasia Treatment Market? Innovative Approaches In Benign Prostatic Hyperplasia Treatment Minimally Invasive Techniques For Enhanced Recovery

Major companies operating in the benign prostatic hyperplasia treatment market are prioritizing the development of innovative solutions, including minimally invasive procedures, to enhance patient outcomes and shorten recovery times. These procedures involve small or no incisions, minimizing trauma, pain, and complications while offering a faster recovery compared to traditional surgical methods. For instance, in December 2022, Teleflex Incorporated, a US-based medical device company, launched the UroLift System to treat benign prostatic hyperplasia. This system utilizes small permanent implants to reposition enlarged prostate tissue, offering significant symptom relief without the need for tissue removal, cutting, or heating. This outpatient treatment ensures rapid recovery, preserves sexual function, and delivers superior symptom relief compared to traditional BPH medications, with side effects typically resolving within two to four weeks.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Benign Prostatic Hyperplasia Treatment Market? Laborie Medical Technologies Acquires Urotronic To Expand Interventional Urology Portfolio

In October 2023, Laborie Medical Technologies, Inc., a US-based medical technology company, acquired Urotronic for $600 million. With this acquisition, Laborie Medical Technologies aims to expand its interventional urology portfolio, enhance its technological capabilities, and strengthen its global market position in minimally invasive urological treatments. Urotronic, Inc. is a US-based medical device company that specifically develops and markets a minimally invasive treatment for benign prostatic hyperplasia (BPH).

What Is The Regional Outlook For The Global Benign Prostatic Hyperplasia Treatment Market?

North America was the largest region in the benign prostatic hyperplasia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Benign Prostatic Hyperplasia Treatment Market?

The benign prostatic hyperplasia treatment market consists of revenues earned by entities by providing services such as pharmacological treatments, minimally invasive procedures, surgical treatments, diagnostic services, and prostatic stents. The market value includes the value of related goods sold by the service provider or included within the service offering. The benign prostatic hyperplasia treatment market also includes sales of transurethral microwave thermotherapy, prostatic urethral lift, acupuncture, combination therapy, phosphodiesterase-5 inhibitors, and minimally invasive devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Benign Prostatic Hyperplasia Treatment Industry?

The benign prostatic hyperplasia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the benign prostatic hyperplasia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Benign Prostatic Hyperplasia Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$8.69 billion
Revenue Forecast In 2034	$10.74 billion
Growth Rate	CAGR of 5.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The benign prostatic hyperplasia treatment market covered in this report is segmented – 1) By Treatment: Minimal Invasive Surgery, Invasive Surgery 2) By Therapeutic Class: Alpha Blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Other Therapeutic classes 3) By End User: Home Healthcare, Hospitals And Clinics, Research And Manufacturing Subsegments: 1) By Minimal Invasive Surgery: Transurethral Resection of the Prostate (TURP), Laser Surgery, Prostatic Urethral Lift, Transurethral Incision of the Prostate (TUIP), Microwave Therapy 2) By Invasive Surgery: Open Prostatectomy, Robotic Prostatectomy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Merck And Co Inc, AbbVie Inc., Bayer AG, Sanofi S.A., GlaxoSmithKline Public Limited Company, Medtronic Public Limited Company, Mezzion Pharma Co Ltd, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Boston Scientific Corporation, Astellas Pharma Inc., Olympus Corporation, Coloplast Group, Teleflex Incorporated, Cook Medical Incorporated, AngioDynamics, Inc., HistoSonics Inc, Urovant Sciences Ltd, UroGen Pharma Ltd., Urologix Inc, Zenflow Inc, Butterfly Medical Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Benign Prostatic Hyperplasia Treatment Market Characteristics

3. Benign Prostatic Hyperplasia Treatment Market Trends And Strategies

4. Benign Prostatic Hyperplasia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Benign Prostatic Hyperplasia Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Benign Prostatic Hyperplasia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Benign Prostatic Hyperplasia Treatment Market Growth Rate Analysis

5.4. Global Benign Prostatic Hyperplasia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Benign Prostatic Hyperplasia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Benign Prostatic Hyperplasia Treatment Total Addressable Market (TAM)

6. Benign Prostatic Hyperplasia Treatment Market Segmentation

6.1. Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Minimal Invasive Surgery

Invasive Surgery

6.2. Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alpha Blockers

5-Alpha Reductase Inhibitors

Phosphodiesterase-5 Inhibitors

Other Therapeutic classes

6.3. Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Home Healthcare

Hospitals And Clinics

Research And Manufacturing

6.4. Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Minimal Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Transurethral Resection of the Prostate (TURP)

Laser Surgery

Prostatic Urethral Lift

Transurethral Incision of the Prostate (TUIP)

Microwave Therapy

6.5. Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Open Prostatectomy

Robotic Prostatectomy

7. Benign Prostatic Hyperplasia Treatment Market Regional And Country Analysis

7.1. Global Benign Prostatic Hyperplasia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Benign Prostatic Hyperplasia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market

8.1. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Benign Prostatic Hyperplasia Treatment Market

9.1. China Benign Prostatic Hyperplasia Treatment Market Overview

9.2. China Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Benign Prostatic Hyperplasia Treatment Market

10.1. India Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Benign Prostatic Hyperplasia Treatment Market

11.1. Japan Benign Prostatic Hyperplasia Treatment Market Overview

11.2. Japan Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Benign Prostatic Hyperplasia Treatment Market

12.1. Australia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Benign Prostatic Hyperplasia Treatment Market

13.1. Indonesia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Benign Prostatic Hyperplasia Treatment Market

14.1. South Korea Benign Prostatic Hyperplasia Treatment Market Overview

14.2. South Korea Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Benign Prostatic Hyperplasia Treatment Market

15.1. Western Europe Benign Prostatic Hyperplasia Treatment Market Overview

15.2. Western Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Benign Prostatic Hyperplasia Treatment Market

16.1. UK Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Benign Prostatic Hyperplasia Treatment Market

17.1. Germany Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Benign Prostatic Hyperplasia Treatment Market

18.1. France Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Benign Prostatic Hyperplasia Treatment Market

19.1. Italy Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Benign Prostatic Hyperplasia Treatment Market

20.1. Spain Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Benign Prostatic Hyperplasia Treatment Market

21.1. Eastern Europe Benign Prostatic Hyperplasia Treatment Market Overview

21.2. Eastern Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Benign Prostatic Hyperplasia Treatment Market

22.1. Russia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Benign Prostatic Hyperplasia Treatment Market

23.1. North America Benign Prostatic Hyperplasia Treatment Market Overview

23.2. North America Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Benign Prostatic Hyperplasia Treatment Market

24.1. USA Benign Prostatic Hyperplasia Treatment Market Overview

24.2. USA Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Benign Prostatic Hyperplasia Treatment Market

25.1. Canada Benign Prostatic Hyperplasia Treatment Market Overview

25.2. Canada Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Benign Prostatic Hyperplasia Treatment Market

26.1. South America Benign Prostatic Hyperplasia Treatment Market Overview

26.2. South America Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Benign Prostatic Hyperplasia Treatment Market

27.1. Brazil Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Benign Prostatic Hyperplasia Treatment Market

28.1. Middle East Benign Prostatic Hyperplasia Treatment Market Overview

28.2. Middle East Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Benign Prostatic Hyperplasia Treatment Market

29.1. Africa Benign Prostatic Hyperplasia Treatment Market Overview

29.2. Africa Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Benign Prostatic Hyperplasia Treatment Market Competitive Landscape And Company Profiles

30.1. Benign Prostatic Hyperplasia Treatment Market Competitive Landscape

30.2. Benign Prostatic Hyperplasia Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck And Co Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Benign Prostatic Hyperplasia Treatment Market Other Major And Innovative Companies

31.1. GlaxoSmithKline Public Limited Company

31.2. Medtronic Public Limited Company

31.3. Mezzion Pharma Co Ltd

31.4. Eli Lilly and Company

31.5. Teva Pharmaceutical Industries Ltd.

31.6. Boehringer Ingelheim

31.7. Boston Scientific Corporation

31.8. Astellas Pharma Inc.

31.9. Olympus Corporation

31.10. Coloplast Group

31.11. Teleflex Incorporated

31.12. Cook Medical Incorporated

31.13. AngioDynamics, Inc.

31.14. HistoSonics Inc

31.15. Urovant Sciences Ltd

32. Global Benign Prostatic Hyperplasia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia Treatment Market

34. Recent Developments In The Benign Prostatic Hyperplasia Treatment Market

35. Benign Prostatic Hyperplasia Treatment Market High Potential Countries, Segments and Strategies

35.1 Benign Prostatic Hyperplasia Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Benign Prostatic Hyperplasia Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Benign Prostatic Hyperplasia Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Minimal Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Benign Prostatic Hyperplasia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Benign Prostatic Hyperplasia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Pfizer Inc. Financial Performance

Table 77: Merck And Co Inc Financial Performance

Table 78: AbbVie Inc. Financial Performance

Table 79: Bayer AG Financial Performance

Table 80: Sanofi S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Minimal Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Benign Prostatic Hyperplasia Treatment Market, Sub-Segmentation Of Invasive Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Benign Prostatic Hyperplasia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Benign Prostatic Hyperplasia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Benign Prostatic Hyperplasia Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Pfizer Inc. Financial Performance

Figure 77: Merck And Co Inc Financial Performance

Figure 78: AbbVie Inc. Financial Performance

Figure 79: Bayer AG Financial Performance

Figure 80: Sanofi S.A. Financial Performance

From Insight to Impact: Strategic Growth Mapping in the HER2-Positive Breast Cancer Market

Hospital And Nursing Home Probiotics Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities

Next-Gen Implantable Cardioverter Defibrillators (ICDs) : Market Forecast, Transformation, and Long-Term Trajectories

Indwelling Catheters Growth Trajectory: Key Forecasts and Strategic Insights

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Drugs For Benign Prostatic hypertrophy Global Market Report 2025 – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Ph...

Prostate Cancer Drugs Global Market Report 2025 – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By End User...

Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025 – By Type (Single Photon Emission Computed Tomography (SPECT), Photon Emission Computed Tomography (PET)), By Test Type (Preliminary Tests, Confirmat...

Prostate Cancer Diagnostics Global Market Report 2025 – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell Cancer, Sm...

Urothelial Carcinoma Treatment Global Market Report 2025 – By Type (Non-Invasive Urothelial Carcinoma Treatment, Invasive Urothelial Carcinoma Treatment), By Treatment (Immunotherapy, Radiotherapy, Chemotherapy), By Canc...

Overactive Bladder Treatment Global Market Report 2025 – By Diseases Type (Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity), By Therapy (Anticholinergics, Mirabegron, Neurostimulation, Intravesical Insti...

Pediatric Bladder Treatment Global Market Report 2025 – By Type (Diurnal Incontinence, Enuresis, Other Types), By Treatment (Urotherapy, Medication, Surgical Reconstruction, Other Treatments), By Route of Administration ...

Frequently Asked Questions

What is the definition of the Benign Prostatic Hyperplasia Treatment market?

How will the Benign Prostatic Hyperplasia Treatment market drivers and restraints affect the market dynamics? What forces will shape the Benign Prostatic Hyperplasia Treatment industry going forward?

The market major growth driver - Rising Adoption Of Minimally Invasive Surgeries Driving Growth In BPH Treatment. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Benign Prostatic Hyperplasia Treatment market?

The benign prostatic hyperplasia treatment market size has grown strongly in recent years. It will grow from $8.23 billion in 2024 to $8.69 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to growing awareness and screening initiatives, rising prevalence of BPH, increasing healthcare awareness, improving healthcare infrastructure, and growing elderly population. The benign prostatic hyperplasia treatment market size is expected to see strong growth in the next few years. It will grow to " $10.74 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to the rising adoption of minimally invasive procedures, a growing number of geriatric patients, a rising availability of advanced treatment options, a growing focus on patient-centric care, and a rising prevalence of comorbidities. Major trends in the forecast period include developing targeted therapies, integration of digital health solutions, innovation in surgical options, integration of 3D imaging for diagnosis, and innovation in patient-centered care models. For further insights on this market, request a sample here

How is the Benign Prostatic Hyperplasia Treatment market segmented?

The benign prostatic hyperplasia treatmentmarket covered in this report is segmented –
1) By Treatment: Minimal Invasive Surgery; Invasive Surgery
2) By Therapeutic Class: Alpha Blockers; 5-Alpha Reductase Inhibitors; Phosphodiesterase-5 Inhibitors; Other Therapeutic classes
3) By End User: Home Healthcare; Hospitals And Clinics; Research And Manufacturing Subsegments:
1) By Minimal Invasive Surgery: Transurethral Resection of the Prostate (TURP); Laser Surgery; Prostatic Urethral Lift; Transurethral Incision of the Prostate (TUIP); Microwave Therapy
2) By Invasive Surgery: Open Prostatectomy; Robotic Prostatectomy For further insights on this market, request a sample here

Which region has the largest share of the Benign Prostatic Hyperplasia Treatment market? What are the other regions covered in the report?

North America was the largest region in the benign prostatic hyperplasia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benign prostatic hyperplasia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Benign Prostatic Hyperplasia Treatment market?

What are the key trends in the Benign Prostatic Hyperplasia Treatment market?

Major trends in this market include Innovative Approaches In Benign Prostatic Hyperplasia Treatment Minimally Invasive Techniques For Enhanced Recovery. For further insights on this market, request a sample here.